Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma [clinicaltrials:NCT00457587]
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma [clinicaltrials:NCT00457587]
Bio2RDF identifier
NCT00457587
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00457587
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples With DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
whole blood for monocytes isolation serum urine
brief summary [clinicaltrials_vocabulary:brief-summary]
Adrenocortical carcinom ...... therapy in patients with ACC.
brief title [clinicaltrials_vocabulary:brief-title]
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2013-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-04-04T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-06-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00457587
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Präklinische Studie Zur Etabli ...... py in Adrenocortical Carcinoma
org study id [clinicaltrials_vocabulary:org-study-id]
Wue-Immuno-ACC-83/05
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2011-12-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
target duration [clinicaltrials_vocabulary:target-duration]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-06-01T00:00:00Z
identifier
clinicaltrials:NCT00457587
title
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
@en
type
label
Preclinical Study Towards an I ...... a [clinicaltrials:NCT00457587]
@en